8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) February 27, 2023

Aflac Incorporated

_________________________________________________________________________________________________________________________________________________________

(Exact name of registrant as specified in its charter)

Georgia	001-07434		58-1167100
(State or other jurisdiction	(Commission		(IRS Employer
of incorporation)	File Number)		Identification No.)
1932 Wynnton Road	Columbus	Georgia	31999
(Address of principal executive offices)			(Zip Code)

706.323.3431

_________________________________________________________________________________________________________________________________________________________

(Registrant’s telephone number, including area code)

_________________________________________________________________________________________________________________________________________________________

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, $.10 Par Value	AFL	New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Item 7.01 Regulation FD.

Aflac Incorporated and its subsidiaries (collectively, "the Company") are updating the Company's Financial Analysts Briefing (“FAB”) Supplement for the period ended December 31, 2022, to reflect the impact to certain 2021 and 2022 data contained in the FAB Supplement as a result of the adoption of the Financial Accounting Standards Board’s Accounting Standard Update 2018-12 Financial Services - Insurance: Targeted Improvements to the Accounting for Long-Duration Contracts, as clarified and amended by (i) ASU 2019-09 Financial Services - Insurance: Effective Date, and (ii) ASU 2020-11 Financial Services - Insurance: Effective Date and Early Application (collectively, “LDTI”) as of January 1, 2023. The amended guidance is applied as of the beginning of the earliest period presented in the Company’s quarterly and annual financial statements, which results in a January 1, 2021 Transition Date. The impacts to the 2021 and 2022 data in the FAB Supplement are being reflected at this time voluntarily and for comparative purposes only. In conjunction with the adoption of LDTI, the Company will change its practice of recording the change in the deferred profit liability on products with limited-payment features from the benefits and claims, net line item to the net earned premiums line item in the consolidated statement of earnings. This change in presentation will have no impact on net earnings and will be made for all comparative periods presented in quarterly and annual financial statements. This change has been reflected in the FAB Supplement, as adjusted for the adoption of LDTI.

The Company is furnishing the FAB Supplement, as adjusted for the adoption of LDTI, as Exhibit 99.1. In accordance with General Instruction B.2 of Form 8-K, the information included or incorporated in this report (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”), nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as shall be set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit Number	Exhibit Title or Description
99.1	Financial Analysts Briefing Supplement (Adjusted for January 1, 2023 LDTI Adoption)
104	Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document)

1

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Aflac Incorporated
February 27, 2023	/s/ June Howard
	(June Howard)
	Senior Vice President, Financial Services
	Chief Accounting Officer

2

EX-99.1

AS ADJUSTEDFINAL

Financial Analysts Briefing Supplement

Fourth Quarter 2022 - As Adjusted

This document is a statistical supplement to the Financial Analysts Briefing (FAB) book. Throughout the presentation, amounts presented may not foot due to rounding. As you review the supplement, please note the non-U.S. GAAP financial measures and definitions found at the back of this document.

The Company adopted the Financial Accounting Standards Board’s Accounting Standard Update 2018-12 Financial Services - Insurance: Targeted Improvements to the Accounting for Long-Duration Contracts, as clarified and amended by (i) ASU 2019-09 Financial Services - Insurance: Effective Date, and (ii) ASU 2020-11 Financial Services - Insurance: Effective Date and Early Application (collectively, “LDTI”) as of January 1, 2023. The amended guidance is applied as of the beginning of the earliest period presented in the Company’s quarterly and annual financial statements, which results in a January 1, 2021 Transition Date. The impacts to the 2021 and 2022 data in the FAB Supplement are being reflected at this time voluntarily and for comparative purposes only. In conjunction with the adoption of LDTI, the Company will change its practice of recording the change in the deferred profit liability on products with limited-payment features from the benefits and claims, net line item to the net earned premiums line item in the consolidated statement of earnings. This change in presentation will have no impact on net earnings and will be made for all comparative periods presented in quarterly and annual financial statements. This change has been reflected in the updated FAB Supplement. Updates to the original FAB Supplement for these items are highlighted in yellow herein.

Aflac Incorporated	Page
Share Data	2
Summary of Adjusted Results by Business Segment	3
Statements of Earnings	4
Analysis of Net Earnings and Net Earnings Per Share	5
Balance Sheets	6
Quarterly Financial Results	7
Quarterly Book Value Per Share	8
Return on Equity	9
Adjusted Earnings Per Share Excluding Current Period Foreign Currency Impact	10
Investment Results	11,12,13
Long-Term Debt Data	14
Ratings	15
Aflac U.S.
Statement of Pretax Adjusted Earnings	16
Balance Sheets	17
Quarterly Pretax Adjusted Earnings	18
Operating Ratios	19
Sales	20,21
Aflac Japan
Statement of Pretax Adjusted Earnings	22,23
Balance Sheets	24,25
Quarterly Pretax Adjusted Earnings	26
Operating Ratios	27
Sales	28,29,30
Yen/Dollar Exchange Rates	31
Corporate and Other
Statement of Pretax Adjusted Earnings	32
Non-U.S. GAAP Financial Measures	33

For more information, contact:

David Young

Phone. 706.596.3264

Aflacir@aflac.com

investors.aflac.com

Aflac Incorporated and Subsidiaries
	Share Data
	(In Thousands)
			Beginning	Shares Issued		Shares Purchased		Ending	QTD Weighted Avg. Shares			YTD Weighted Avg. Shares
			Shares	Stk. Bon.	Stk. Opt.	Treas.	Misc.	Shares	Avg.	Dilutive	Avg.	Avg.	Dilutive	Avg.
		Period	Outstanding	& DRP	& Misc.	Shares	Purch.(1)	Outstanding	Shares	Shares	Diluted	Shares	Shares	Diluted
	2020	1	726,793	468	1,613	9,984	508	718,382	724,366	3,146	727,512	724,366	3,146	727,512
		2	718,382	648	100	5,209	13	713,908	717,889	1,875	719,764	721,128	2,510	723,638
		3	713,908	468	134	10,916	20	703,574	711,698	2,095	713,793	717,962	2,372	720,333
		4	703,574	437	235	11,791	1	692,454	701,016	2,843	703,859	713,702	2,490	716,192
	2021	1	692,454	387	1,684	13,440	378	680,707	688,938	3,002	691,940	688,938	3,002	691,940
		2	680,707	330	130	9,174	3	671,990	678,050	2,871	680,921	683,464	2,936	686,400
		3	671,990	250	188	9,572	39	662,817	668,762	3,163	671,925	678,509	3,012	681,521
		4	662,817	249	224	11,140	18	652,132	659,100	3,412	662,512	673,617	3,112	676,729
	2022	1	652,132	259	1,308	8,007	343	645,349	649,753	3,074	652,827	649,753	3,074	652,827
		2	645,349	269	101	11,185	8	634,526	640,707	2,536	643,243	645,205	2,805	648,010
		3	634,526	258	144	11,057	3	623,868	629,350	2,597	631,947	639,862	2,735	642,597
		4	623,868	222	120	8,938	16	615,256	619,845	3,149	622,994	634,816	2,839	637,655

(1) Includes previously owned shares used to purchase options (swapped shares) and/or shares purchased for deferred compensation program

2

Aflac Incorporated and Subsidiaries
	Summary of Adjusted Results by Business Segment
	(In Millions, except per-share data and where noted)
		Years Ended December 31,															3 Months Ended December 31,							12 Months Ended December 31,
																							%							%
		2017			2018			2019			2020			2021			2021			2022			Change	2021			2022			Change
	Aflac Japan	$	3,054		$	3,208		$	3,261		$	3,263		$	3,755		$	897		$	720		(19.7)	$	3,755		$	3,281		(12.6)
	Aflac U.S.		1,245			1,285			1,272			1,268			1,356			282			339		20.2		1,356			1,359		.2
	Corporate and other (1)		(214)			(139)			(72)			(115)			(293)			(152)			(45)				(293)			(218)
	Pretax adjusted earnings		4,086			4,354			4,461			4,416			4,819			1,026			1,015		(1.1)		4,819			4,422		(8.2)
	Income taxes (1)		1,370			1,129			1,147			864			893			151			198		31.1		893			808		(9.5)
	Adjusted earnings (2)		2,716			3,226			3,314			3,552			3,925			875			817		(6.6)		3,925			3,614		(7.9)
	Reconciling items:
	Adjusted net investment gains (losses)		—			(297)			(15)			(229)			462			246			(477)				462			447
	Other and non-recurring income (loss) (3)		(69)			(75)			(1)			(28)			(73)			(6)			—				(73)			1
	Income tax benefit (expense) on items excluded from adjusted earnings (4)		24			83			3			72			(83)			(50)			(144)				(83)			357
	Tax reform adjustment (5)		1,933			(18)			4			—			—			—			—				—			—
	Tax valuation allowance release (6)		—			—			—			1,411			—			—			—				—			—
	Net earnings	$	4,604		$	2,920		$	3,304		$	4,778		$	4,231		$	1,065		$	196		(81.6)	$	4,231		$	4,418		4.4
	Effective Tax rate		(14.6)	%		26.7	%		25.7	%		(14.9)	%		18.7	%		15.9	%		63.6	%			18.7	%		9.3	%
	Earnings per share of common stock:
	Net earnings (basic)	$	5.81		$	3.79		$	4.45		$	6.69		$	6.28		$	1.62		$	0.32		(80.2)	$	6.28		$	6.96		10.8
	Net earnings (diluted)		5.77			3.77			4.43			6.67			6.25			1.61			0.31		(80.7)		6.25			6.93		10.9
	Adjusted earnings (basic) (2)	$	3.43		$	4.20		$	4.46		$	4.98		$	5.83		$	1.33		$	1.32		(.8)	$	5.83		$	5.69		(2.4)
	Adjusted earnings (diluted) (2)		3.40			4.16			4.44			4.96			5.80			1.32			1.31		(.8)		5.80			5.67		(2.2)
	(1) The change in value of federal historic rehabilitation and solar investments in partnerships of $11 and $104 for the three-month periods and $91 and $138 for the twelve-month periods ended December 31, 2022, and 2021, respectively is included as a reduction to net investment income. Tax credits on these investments of $20 and $80 for the three-month period and $83 and $115 for the twelve-month periods ended December 31, 2022, and 2021, respectively, have been recorded as an income tax benefit in the consolidated statement of earnings.
	(2) See non-U.S. GAAP financial measures for definition of adjusted earnings.
	(3) Foreign currency gains and losses for all periods have been reclassified from Other and non-recurring income (loss) to Net investment gains and losses.
	(4) Primarily reflects release of $452 in deferred taxes in 2022
	(5) The impact of Tax Reform was adjusted in 2018 for return-to-provision adjustments, various amended returns filed by the Company, and final true-ups of deferred tax liabilities. Further impacts were recorded in 2019 as a result of additional guidance released by the IRS.
	(6) Tax benefit recognized in 2020 represents the release of valuation allowances on deferred tax benefits related to foreign tax credits.

3

Aflac Incorporated and Subsidiaries
	Consolidated Statements of Earnings - U.S. GAAP
	(In Millions, except per-share data)
			Years Ended December 31,										3 Months Ended December 31,					12 Months Ended December 31,
																	%					%
			2017		2018		2019		2020		2021		2021		2022		Change	2021		2022		Change
	Revenues:
		Net earned premiums
		Gross premiums	$	18,875	$	19,018	$	19,122	$	18,955	$	17,305	$	4,180	$	3,553		$	17,305	$	15,025
		Assumed (ceded)		(345)		(341)		(342)		(333)		(210)		(48)		(30)			(210)		(124)
		Total net earned premiums		18,531		18,677		18,780		18,622		17,095		4,132		3,523	(14.7)		17,095		14,901	(12.8)
		Net investment income		3,220		3,442		3,578		3,638		3,818		910		896	(1.5)		3,818		3,656	(4.2)
		Net investment gains (losses) (1)		(151)		(430)		(135)		(270)		468		243		(521)			468		363
		Other income (1)		67		69		84		157		173		37		50			173		220
		Total revenues		21,667		21,758		22,307		22,147		21,554		5,322		3,948	(25.8)		21,554		19,140	(11.2)
	Benefits and Claims:
		Benefits and claims, net
		Incurred claims -direct		8,853		9,121		9,279		9,364		8,949		2,199		1,826			8,949		8,271
		Incurred claims -assumed (ceded)		(446)		(421)		(372)		(296)		(147)		(24)		(18)			(147)		(108)
		Increase in FPB (2)-direct		3,628		3,167		2,952		2,707		1,819		370		312			1,819		888
		Increase in FPB (2)-assumed (ceded)		146		133		83		21		3		2		(3)			3		51
		Total net benefits and claims, excluding   reserve remeasurement		N/A		N/A		N/A		N/A		10,623		2,547		2,117			10,623		9,102
		Reserve remeasurement gain (loss)		N/A		N/A		N/A		N/A		(147)		(17)		(63)			(147)		(215)
		Total net benefits and claims		12,181		12,000		11,942		11,796		10,476		2,529		2,054	(18.8)		10,476		8,887	(15.2)
		Acquisition and operating expenses:
		Amortization of DAC (3)		1,132		1,245		1,282		1,214		835		208		194			835		792
		Insurance commissions		1,316		1,320		1,321		1,316		1,256		304		271			1,256		1,117
		Insurance expenses		2,780		2,988		3,089		3,420		3,541		958		836			3,541		3,249
		Interest expense		240		222		228		242		238		57		55			238		226
		Other expenses		—		—		—		—		—		—		—			—		—
		Total acquisition and operating expenses		5,468		5,775		5,920		6,192		5,870		1,527		1,356	(11.2)		5,870		5,384	(8.3)
		Total benefits and claims		17,649		17,775		17,862		17,988		16,346		4,056		3,410	(15.9)		16,346		14,271	(12.7)
		Pretax earnings		4,018		3,983		4,445		4,159		5,208		1,266		538			5,208		4,869
		Income tax expense (benefit) (4)		(586)		1,063		1,141		(619)		977		201		342			977		451
		Net earnings	$	4,604	$	2,920	$	3,304	$	4,778	$	4,231	$	1,065	$	196	(81.6)	$	4,231	$	4,418	4.4
		(1) Foreign currency gains and losses for all periods have been reclassified from Other income to Net investment gains and losses for consistency with current period presentation.
		(2) Future policy benefits
		(3) Deferred acquisition costs
		(4) Primarily reflects release of $452 in deferred taxes in 2022

4

Aflac Incorporated and Subsidiaries
Analysis of Net Earnings and Net Earnings Per Diluted Share
(In Millions, except for per-share data)
									Other and	Foreign
				Net	Other and Non-	Foreign	Net	Net	Non-Recurring	Currency
			Net	Investment	Recurring	Currency	Earnings	Investment	Items	Impact
		Period	Earnings	Gains (Losses) (1)	Items (1)(3)(4)	Impact (2)	Per Share	Gains (Losses) (1)	Per Share (1)(3)(4)	Per Share (2)
		2017	4,604	—	1,888	(41)	5.77	—	2.37	(.05)
		2018	2,920	(230)	(76)	28	3.77	(.30)	(.09)	.04
		2019	3,304	(13)	3	15	4.43	(.02)	.01	.02
		2020	4,778	(181)	1,407	31	6.67	(.25)	1.96	.04
		2021	4,231	365	(59)	(42)	6.25	.54	(.09)	(.06)
		2022	4,418	803	1	(262)	6.93	1.26	—	(.41)
	2020	1	566	(322)	5	9	.78	(.44)	.01	.01
		2	805	(116)	—	5	1.12	(.16)	—	.01
		3	2,456	45	1,418	3	3.44	.06	1.99	—
		4	951	212	(15)	14	1.35	.30	(.02)	.02
	2021	1	1,224	240	(5)	5	1.77	.35	(.01)	.01
		2	1,027	67	(42)	(6)	1.51	.10	(.06)	(.01)
		3	915	(136)	(7)	(12)	1.36	(.20)	(.01)	(.02)
		4	1,065	194	(5)	(29)	1.61	.29	(.01)	(.04)
	2022	1	1,047	106	—	(35)	1.60	.16	—	(.05)
		2	1,394	448	—	(59)	2.17	.70	—	(.09)
		3	1,781	871	1	(97)	2.82	1.38	—	(.15)
		4	196	(621)	—	(70)	.31	(1.00)	—	(.11)
	(1) Items are presented net of tax.
	(2) See non-U.S. GAAP financial measures for definition of adjusted earnings excluding current period foreign currency impact
	(3) Foreign currency gains and losses and amortized hedge costs/income for all periods have been reclassified from Other income to Net investment gains and losses for consistency with current period presentation.
	(4 )Tax benefit recognized in the third quarter of 2020 represents the release of valuation allowances on deferred tax benefits related to foreign tax credits.

5

Aflac Incorporated and Subsidiaries
	Consolidated Balance Sheets
	(In Millions, except per-share data)
				December 31,
	Assets:			2017		2018		2019		2020		2021		2022
	Investments and cash:
		Securities available for sale:
		Fixed maturity securities available for sale, at fair value		$	78,804	$	78,429	$	86,950	$	101,286	$	94,206	$	71,936
		Fixed maturity securities available for sale - consolidated variable interest entities, at fair value			5,509		4,466		4,312		4,596		4,490		3,805
		Fixed maturity securities held to maturity, at amortized cost, net of allowance for credit losses			31,430		30,318		30,085		24,464		22,000		19,056
		Equity securities, at fair value			1,023		987		802		1,283		1,603		1,091
		Commercial mortgage and other loans, net of allowance for credit losses			3,002		6,919		9,569		10,554		11,786		13,496
		Other investments			400		787		1,477		2,429		3,842		4,070
		Cash and cash equivalents			3,491		4,337		4,896		5,141		5,051		3,943
			Total investments and cash		123,659		126,243		138,091		149,753		142,978		117,397
	Receivables, net of allowance for credit losses (1)				820		844		816		778		672		647
	Accrued investment income				769		773		772		780		737		745
	Deferred policy acquisition costs				9,505		9,875		10,128		10,441		9,848		9,239
	Property and equipment, net				434		443		581		601		538		530
	Other assets, net of allowance for credit losses (1) (2)				2,030		2,228		2,380		2,733		3,377		3,180
			Total assets	$	137,217	$	140,406	$	152,768	$	165,086	$	158,150	$	131,738
	Liabilities and Shareholders' Equity:
	Liabilities:
		Total policy liabilities		$	99,147	$	103,188	$	106,554	$	114,391	$	126,331	$	96,910
		Notes payable			5,289		5,778		6,569		7,899		7,956		7,442
		Income taxes, primarily deferred			4,745		4,020		5,370		4,661		30		698
		Other liabilities			3,438		3,958		5,316		4,576		6,802		6,548
			Total liabilities		112,619		116,944		123,809		131,527		141,119		111,598
	Shareholders' equity:
		Common stock			135		135		135		135		135		135
		Additional paid-in capital			2,052		2,177		2,313		2,410		2,529		2,641
		Retained earnings			29,895		31,788		34,291		37,984		40,963		44,367
		Accumulated other comprehensive income (loss):
			Unrealized foreign currency translation gains (losses)		(1,750)		(1,847)		(1,623)		(1,109)		(1,985)		(3,564)
			Unrealized gains (losses) on fixed maturity securities		5,964		4,234		8,548		10,361		9,602		(702)
			Unrealized gains (losses) on derivatives		(23)		(24)		(33)		(34)		(30)		(27)
			Effect on change in discount rate assumption(s)		N/A		N/A		N/A		N/A		(15,832)		(2,100)
			Pension liability adjustment		(163)		(212)		(277)		(284)		(166)		(36)
		Treasury stock			(11,512)		(12,789)		(14,395)		(15,904)		(18,185)		(20,574)
			Total shareholders' equity		24,598		23,462		28,959		33,559		17,031		20,140
			Total liabilities & shareholders' equity	$	137,217	$	140,406	$	152,768	$	165,086	$	158,150	$	131,738

(1) Certain reclassifications have been made to prior-year amounts to conform to current-year reporting classifications. These reclassifications had no impact on net earnings or total shareholders' equity

(2) Includes goodwill of $265 million in 2022, $268 in 2021, $269 in 2020, $140 million in 2019, $67 million in 2018 and $67 million in 2017

6

Aflac Incorporated and Subsidiaries
Quarterly Financial Results
(Dollars In Millions, except per-share data)
							Total
			Net	Net		Benefits	Acquisitions	Total			Net EPS		Adj. EPS (1)
			Earned	Inv.	Total	&	&	Pretax	Net	Adjusted
		Period	Premiums	Income	Revenues	Claims, net	Adj. Exp.	Earn.	Earn.	Earn. (1)	Basic	Dil.	Basic	Dil.
		2017	18,531	3,220	21,667	12,181	5,468	4,018	4,604	2,716	5.81	5.77	3.43	3.40
		2018	18,677	3,442	21,758	12,000	5,775	3,983	2,920	3,226	3.79	3.77	4.20	4.16
		2019	18,780	3,578	22,307	11,942	5,920	4,445	3,304	3,314	4.45	4.43	4.46	4.44
		2020	18,622	3,638	22,147	11,796	6,192	4,159	4,778	3,552	6.69	6.67	4.98	4.96
		2021	17,095	3,818	21,554	10,476	5,870	5,208	4,231	3,925	6.28	6.25	5.83	5.80
		2022	14,901	3,656	19,140	8,887	5,384	4,869	4,418	3,614	6.96	6.93	5.69	5.67
	2020	1	4,681	904	5,162	2,939	1,503	720	566	882	0.78	0.78	1.22	1.21
		2	4,664	870	5,407	2,897	1,440	1,070	805	921	1.12	1.12	1.28	1.28
		3	4,623	896	5,665	2,985	1,527	1,153	2,456	994	3.45	3.44	1.40	1.39
		4	4,653	968	5,913	2,974	1,723	1,216	951	755	1.36	1.35	1.08	1.07
	2021	1	4,434	925	5,710	2,771	1,420	1,519	1,224	989	1.78	1.77	1.44	1.43
		2	4,301	993	5,424	2,672	1,474	1,277	1,027	1,002	1.51	1.51	1.48	1.47
		3	4,229	991	5,098	2,503	1,450	1,146	915	1,058	1.37	1.36	1.58	1.57
		4	4,132	910	5,322	2,529	1,527	1,266	1,065	875	1.62	1.61	1.33	1.32
	2022	1	4,079	903	5,173	2,483	1,396	1,295	1,047	942	1.61	1.60	1.45	1.44
		2	3,764	937	5,315	2,274	1,334	1,708	1,394	945	2.18	2.17	1.47	1.47
		3	3,535	920	4,704	2,076	1,299	1,329	1,781	910	2.83	2.82	1.45	1.44
		4	3,523	896	3,948	2,054	1,356	538	196	817	0.32	0.31	1.32	1.31

(1) See non-U.S. GAAP financial measures for definition of adjusted earnings.

7

Aflac Incorporated and Subsidiaries
Quarterly Book Value Per Share
(Dollars In Millions, except per-share data)
								Adjusted BV
							Adjusted BV	Per Share Incl
			Equity	AOCI		Adjusted BV	Per Share Incl	Foreign Currency
			BV Per	BV Per	Adjusted BV	Per Share	Foreign Currency	Translation G/(L)
		Period	Share	Share	Per Share (1)	% Change	Translation G/(L)(1)	% Change
		2017	31.50	5.16	26.34	19.7%	24.10	23.3%
		2018	31.06	2.85	28.22	7.1%	25.77	6.9%
		2019	39.84	9.10	30.74	8.9%	28.51	10.6%
		2020	48.46	12.90	35.56	15.7%	33.96	19.1%
		2021	26.12	(12.90)	39.01	9.7%	35.97	5.9%
		2022	32.73	(10.45)	43.18	10.7%	37.39	3.9%
	2020	1	36.75	5.83	30.92	7.0%	28.77	8.9%
		2	41.21	9.45	31.75	7.5%	29.70	7.7%
		3	46.16	11.25	34.91	15.7%	33.08	17.4%
		4	48.46	12.90	35.56	15.7%	33.96	19.1%
	2021	1	22.98	(13.60)	36.59	18.3%	34.15	18.7%
		2	24.39	(13.18)	37.57	18.3%	35.12	18.2%
		3	25.19	(13.20)	38.39	10.0%	35.77	8.1%
		4	26.12	(12.90)	39.01	9.7%	35.97	5.9%
	2022	1	27.21	(13.09)	40.30	10.1%	36.53	7.0%
		2	30.82	(11.00)	41.82	11.3%	36.75	4.6%
		3	31.97	(12.03)	44.00	14.6%	36.99	3.4%
		4	32.73	(10.45)	43.18	10.7%	37.39	3.9%

(1) See non-U.S. GAAP financial measures for definition of adjusted book value and adjusted book value including unrealized foreign currency translation gains and losses.

8

Aflac Incorporated and Subsidiaries
	Return on Equity
				Year Ended December 31,
				2017		2018		2019		2020		2021(4)		2022
	U.S. GAAP ROE (1) - Net earnings			20.4	%	12.2	%	12.6	%	15.3	%	26.7	%		23.8	%
		Impact of excluding unrealized foreign currency translation gains (losses)		(2.0)		(1.0)		(1.0)		(0.9)		(1.7)			(2.5)
		Impact of excluding unrealized gains (losses) on securities and derivatives		5.8		3.0		3.6		6.2		10.7			4.1
		Impact of excluding effect on change in discount rate assumptions		N/A		N/A		N/A		N/A		(18.5)			(8.2)
		Impact of excluding pension liability adjustment		(0.2)		(0.1)		(0.1)		(0.2)		(0.2)			(0.1)
			Impact of excluding AOCI	3.6		1.8		2.5		5.1		(9.7)			(6.8)
	U.S. GAAP ROE - less AOCI			24.0		13.9		15.1		20.3		17.0			17.0
	Differences between adjusted earnings and net earnings (2)			(9.8)		1.5		0.0		(5.2)		(1.2)			(3.1)
	Adjusted ROE - reported (3)			14.2		15.4		15.2		15.1		15.8			13.9
		(1)	U.S. GAAP ROE is calculated by dividing net earnings (annualized) by average shareholders' equity.
		(2)	See separate reconciliation of net income to adjusted earnings.
		(3)	Impact of foreign currency is calculated by restating all foreign currency components of the income statement to the weighted average foreign currency exchange rate for the comparable prior year period.
		(4)	Return on equity calculations for 2021 use beginning retained earnings and accumulated other comprehensive income adjusted for the adoption of LDTI.

9

Aflac Incorporated and Subsidiaries
	Adjusted Earnings Per Share Excluding Current Period Foreign Currency Impact (1)
		(Diluted Basis)
												Change
								QTD	YTD	Excluding		Excluding
								Foreign	Foreign	Foreign		Foreign
				Adjusted				Currency	Currency	Currency		Currency
			Period	EPS(1)		Growth		Impact(1)	Impact(1)	Impact(1)		Impact
			2017	$	3.40	4.6	%	N/A	(.05)	$	3.45	6.2	%
			2018	$	4.16	22.4	%	N/A	.04	$	4.13	21.5	%
			2019	$	4.44	6.7	%	N/A	.02	$	4.42	6.3	%
			2020	$	4.96	11.7	%	N/A	.04	$	4.92	10.8	%
			2021	$	5.80	16.9	%	N/A	(.06)	$	5.86	18.1	%
			2022	$	5.67	(2.2)	%	N/A	(.41)	$	6.08	4.8	%
		2020	1	$	1.21	8.0	%	.01	.01	$	1.20	7.1	%
			2	1.28		13.3		.01	.02	1.27		12.4
			3	1.39		19.8		—	.02	1.39		19.8
			4	1.07		3.9		.02	.04	1.05		1.9
				$	4.96	11.7	%			$	4.92	10.8	%
		2021	1	$	1.43	18.2	%	.01	.01	$	1.42	17.4	%
			2	1.47		14.8		(.01)	—	1.48		15.6
			3	1.57		12.9		(.02)	(.02)	1.59		14.4
			4	1.32		23.4		(.04)	(.06)	1.36		27.1
				$	5.80	16.9	%			$	5.86	18.1	%
		2022	1	$	1.44	.7	%	(.05)	(.05)	$	1.50	4.9	%
			2	1.47		—		(.09)	(.15)	1.56		6.1
			3	1.44		(8.3)		(.15)	(.30)	1.59		1.3
			4	1.31		(.8)		(.11)	(.41)	1.43		8.3
				$	5.67	(2.2)	%			$	6.08	4.8	%
		(1) See non-U.S.GAAP financial measures for definition of adjusted earnings and adjusted earnings excluding current period foreign currency impact

10

Aflac Incorporated and Subsidiaries
	Composition of Invested Assets
	(In Millions)
			December 31,
			2017			2018			2019			2020			2021			2022
	Fixed Maturity Securities(1)		$	106,562		$	107,174		$	109,456		$	116,056		$	107,369		$	94,525
	Commercial mortgage and other loans, net of allowance for credit losses (1)
	Transitional Real Estate (floating rate)			1,235			4,378			5,450			5,231			5,246			6,455
	Middle Market Loans (floating rate)			859			1,478			2,412			3,635			4,601			5,028
	Commercial Mortgage Loans			908			1,063			1,707			1,688			1,874			2,013
		Total Commercial mortgage and other loans, net of allowance for credit losses(1)		3,002			6,919			9,569			10,554			11,721			13,496
	Equity Securities, at FV through net earnings			846			987			802			1,283			1,603			1,091
	Alternatives(2)			113			370			551			919			1,703			2,107
	Total Portfolio		$	110,523		$	115,450		$	120,378		$	128,812		$	122,396		$	111,219
	Unrealized Gains (Losses) on Invested Assets
	(In Millions)
			December 31,
			2017			2018			2019			2020			2021			2022
	Fixed Maturity Securities
	Available For Sale - Gross Gains		$	9,985		$	7,733		$	12,266		$	14,771		$	13,566		$	4,800
	Available For Sale - Gross Losses			(804)			(1,694)			(375)			(481)			(239)			(4,528)
	Total Available For Sale			9,181			6,039			11,891			14,290			13,327			272
	Held to Maturity - Gross Gains			6,651			6,470			7,519			5,935			4,869			2,154
	Held to Maturity - Gross Losses			(9)			(66)			(10)			—			—			—
	Total Held to Maturity		$	6,642		$	6,404		$	7,509		$	5,935		$	4,869		$	2,154
		Credit Ratings on Fixed Maturities
		(At Amortized Cost)
			December 31,
		Credit Rating	2017			2018			2019			2020			2021			2022
		AAA		1.0	%		1.0	%		1.1	%		1.0	%		1.0	%		1.6	%
		AA		3.9			3.9			4.3			4.5			5.1			5.2
		A		65.8			67.9			68.6			69.3			68.9			68.0
		BBB		24.0			23.2			23.1			21.9			22.5			23.0
		BB or Lower		5.3			4.0			2.9			3.3			2.5			2.2
				100.0	%		100.0	%		100.0	%		100.0	%		100.0	%		100.0	%
	(1) Presented at amortized cost, net of reserves beginning in 2020
	(2) Presented at carrying value; includes asset classes such as private equity and real estate managed by Global Investments; excludes Corporate driven activity

11

Aflac Incorporated and Subsidiaries
			Supplemental Investment Data by Segment
																						3 Months Ended
				December 31,																		December 31,
				2017			2018			2019			2020			2021			2022			2021			2022
	Aflac Japan:
		Invested assets (in millions)(1)		¥	11,017,560		¥	11,442,444		¥	11,784,586		¥	11,936,087		¥	12,405,531		¥	12,617,181		¥	12,405,531		¥	12,617,181
		Return on average invested assets(2)		2.31		%	2.33		%	2.33		%	2.38		%	2.72		%	2.78		%	2.83		%	2.70		%
		Portfolio book yield at end of period(3)		2.56		%	2.61		%	2.64		%	2.59		%	2.60		%	3.06		%	2.60		%	3.06		%
		Total purchases for period (in millions)(3)		¥	1,078,586		¥	1,298,376		¥	1,003,885		¥	714,124		¥	952,038		¥	716,964		¥	262,311		¥	82,065
		New money yield(3)(4)		1.98		%	3.06		%	3.83		%	3.75		%	3.50		%	4.48		%	3.82		%	6.81		%
	Aflac U.S.:
		Invested assets (in millions)(1)		$	13,764		$	13,798		$	14,036		$	14,848		$	15,841		$	16,772		$	15,841		$	16,772
		Return on average invested assets(2)		5.07		%	5.16		%	5.70		%	4.90		%	4.87		%	4.72		%	4.98		%	4.65		%
		Portfolio book yield at end of period(3)		5.52		%	5.55		%	5.40		%	5.18		%	4.94		%	5.39		%	4.94		%	5.39		%
		Total purchases for period (in millions)(3)		$	1,434		$	2,155		$	1,835		$	1,050		$	2,130		$	1,701		$	778		$	307
		New money yield(3)(4)		4.49		%	4.55		%	4.51		%	3.04		%	3.41		%	5.16		%	3.10		%	6.30		%
	Hedge Costs/Income Metrics (5)(6)
																						3 Months Ended
				December 31,																		December 31,
				2017			2018			2019			2020			2021			2022			2021			2022
	Aflac Japan:
			FX hedged notional at end of period (in billions)(7)	$	9.3		$	9.9		$	8.8		$	6.0		$	6.4		$	4.1		$	6.4		$	4.1
			Weighted average remaining tenor (in months)(8)	27.7			21.4			8.5			13.0			2.6			0.7			2.6			0.7
			Amortized hedge costs for period (in millions)	$	(228)		$	(236)		$	(257)		$	(206)		$	(76)		$	(112)		$	(21)		$	(28)
	Corporate and Other (Parent Company):
			FX hedged notional at end of period (in billions)(7)	$	—		$	2.5		$	4.9		$	5.0		$	5.0		$	5.0		$	5.0		$	5.0
			Weighted average remaining tenor (in months)(8)	—			16.1			13.7			12.1			11.5			10.8			11.5			10.8
			Amortized hedge income (costs) for period (in millions)	$	—		$	36		$	89		$	97		$	57		$	68		$	12		$	25
	(1) Invested assets, including cash and short term investments, are stated at amortized cost; except for equities, which are at fair value.
	(2) Net of investment expenses and amortized hedge costs, year-to-date number reflected on a quarterly average basis
	(3) Includes fixed maturity securities, commercial mortgage and other loans, equity securities, and excludes alternative investments in limited partnerships, and any impacts from hedging      activities
	(4) Reported on a gross yield basis; excludes investment expenses, external management fees, and amortized hedge costs
	(5) See non-U.S. GAAP financial measures for definition of amortized hedge costs/income. Further, the metrics in this table are split to show the hedging of the market value of a portion of the USD investments in Japan Segment’s "USD Program" in the "Japan Segment Portfolio Allocation by Currency" table on page 13 of this supplement as well as the corporate hedging activities at Aflac Inc.
	(6) Aflac Japan and the Parent Company utilize foreign currency forwards and options to hedge foreign currency exchange rate risk. The hedge cost/income on the table above reflects our FX forward protection of the hedged USD portfolio, and hedge costs on one sided options used as caps, and on tail-risk put options. The table does not include the notional amount and weighted average remaining tenor for these options. At December 31, 2022, Aflac Japan caps and put options notional amount was $13.5 billion with a weighted average remaining tenor of 6.4 months. At December 31, 2022, the Parent Company caps notional amount was $2.6 billion with a weighted average remaining tenor of 9.0 months.
	(7) Notional is reported net of any offsetting positions within Aflac Japan or the Parent Company, respectively.
	(8) Tenor based on period reporting date to settlement date

12

Aflac Incorporated and Subsidiaries
		Japan Segment Portfolio Allocation by Currency (1)
		(Dollars In Millions, U.S. GAAP Basis)
			December 31, 2021				December 31, 2022
			Amortized Cost (2)		Fair Value		Amortized Cost (2)		Fair Value
	JGB		$	50,186	$	57,862	$	42,618	$	44,178
	Other		23,661		27,684		20,930		21,277
	Total yen denominated		73,847		85,546		63,548		65,455
	USD Program		28,913		31,946		27,212		27,885
	Other		2,236		3,328		2,209		2,795
	US dollar denominated		31,149		35,274		29,421		30,680
	Total		$	104,996	$	120,820	$	92,969	$	96,135
		Distribution of Consolidated Fixed Maturities by Sector
							December 31, 2022
	(In millions)						Amortized Cost (2)		% of Total
	Government and agencies						$	43,854	46.4		%
	Municipalities						2,590		2.7
	Mortgage- and asset-backed securities						2,167		2.3
	Public utilities						7,450		7.9
	Electric						6,036		6.4
	Natural Gas						249		.3
	Other						565		.6
	Utility/Energy						600		.6
	Sovereign and supranational						1,238		1.3
	Banks/financial institutions						9,340		9.9
	Banking						5,633		6.0
	Insurance						1,703		1.8
	Other						2,004		2.1
	Other corporate						27,886		29.5
	Basic Industry						2,452		2.6
	Capital Goods						3,394		3.6
	Communications						2,866		3.0
	Consumer Cyclical						2,206		2.3
	Consumer Non-Cyclical						6,238		6.7
	Energy						2,664		2.8
	Other						1,371		1.5
	Technology						3,534		3.7
	Transportation						3,161		3.3
	Total fixed maturity securities						$	94,525	100.0		%
	(1) The entire U.S. segment investment portfolio is U.S. dollar denominated.
	(2) Net of reserves

13

Aflac Incorporated and Subsidiaries
Long-Term Debt Data
Adjusted Leverage Ratios
(In Millions)
		December 31,
			2017			2018			2019			2020			2021			2022
	Notes payable	$	5,289		$	5,778		$	6,569		$	7,899		$	7,956		$	7,442
	50% of subordinated debentures and perpetual bonds		(263)			(268)			(407.5)			(432)			(389)			(337)
	Pre-funding of debt maturities		—			—			(348)			—			—			—
	Adjusted debt (1)		5,026			5,510			5,814			7,467			7,568			7,105
	Total Shareholders' Equity		24,598			23,462			28,959			33,559			17,031			20,140
	Accumulated other comprehensive (income) loss:
	Unrealized foreign currency translation (gains) losses		1,750			1,847			1,623			1,109			1,985			3,564
	Unrealized (gains) losses on fixed maturity securities		(5,964)			(4,234)			(8,548)			(10,361)			(9,602)			702
	Unrealized (gains) losses on derivatives		23			24			33			34			30			27
	Effect on change in discount rate assumptions		N/A			N/A			N/A			N/A			15,832			2,100
	Pension liability adjustment		163			212			277			284			166			36
	Adjusted book value (1)		20,570			21,311			22,344			24,625			25,442			26,569
	Adjusted capitalization ex-AOCI (1) (2)	$	25,859		$	27,089		$	28,565		$	32,524		$	33,398		$	34,011
	Adjusted debt to adjusted capitalization ex-AOCI		19.4	%		20.3	%		20.4	%		23.0	%		22.7	%		20.9	%
	Adjusted capitalization (1) (3)	$	23,946		$	25,030		$	26,665		$	31,131		$	31,247		$	30,411
	Adjusted debt to adjusted capitalization		21.0	%		22.0	%		21.8	%		24.0	%		24.2	%		23.4	%

Debt Maturities(4)
(In Millions)
December 31, 2022
		≤ 1 year		1 > 5 years		5 > 10 years		10 > 20 years		20 years +		Total
	Senior Notes	$	—	$	1,334	$	2,997	$	1,153	$	1,191	$	6,675
	Subordinated debt		—		—		—		—		678		678
	Total	$	—	$	1,334	$	2,997	$	1,153	$	1,869	$	7,353

(1) See non-U.S. GAAP financial measures for definition of: adjusted debt; adjusted book value; adjusted debt, including 50% of subordinated debentures and perpetual bonds; and adjusted book value, including unrealized foreign currency translation gains and losses and pension liability adjustment

(2) Adjusted capitalization ex-AOCI is the sum of adjusted debt, including 50% of subordinated debentures and perpetual bonds, plus adjusted book value

(3)Adjusted capitalization is sum of adjusted debt, including 50% of subordinated debentures and perpetual bonds, plus adjusted book value, including unrealized foreign currency translation gains and losses and pension liability adjustment

(4) Debt maturity amounts do not include discounts, premiums, deferred charges, or capital lease obligations.

14

Aflac Incorporated and Subsidiaries

	Insurer Financial Strength Ratings
		AM Best	Moody's	S&P	JCR	R&I
	U.S. Operating Companies
	Aflac of Columbus	A+	Aa3	A+	AA	AA
	Aflac of New York	A+	_	A+	_	_
	Continental American Insurance Company	A+	_	_	_	_
	Japan Operating Company
	Aflac Life Insurance Japan Ltd.	A+	Aa3	A+	AA	AA
	Bermuda Operating Company
	Aflac Re Bermuda Ltd.	_	_	_	AA	_
Issuer Credit Ratings
		AM Best	Moody's	S&P	JCR	R&I
	Aflac Incorporated
	Long-term Senior Debt	a	A3	A-	A+	A+
	Junior Subordinated Debt	a-	Baa1	BBB	_	A-
	Aflac of Columbus
	Long-term Senior Debt	aa	_	A+	AA	_
	Aflac Life Insurance Japan, Ltd.
	Long-term Senior Debt	aa	_	A+	AA	_
	Subordinated Bonds	_	_	_	AA-	_
	The outlook for all ratings assigned by A.M. Best, S&P, Moody's, JCR and R&I is stable.

15

Aflac U.S.
	Statements of Pretax Adjusted Earnings
	(Before Management Fee)
	(In Millions)
			Years Ended December 31,										3 Months Ended December 31,					12 Months Ended December 31,
																	%					%
			2017		2018		2019		2020			2021		2021		2022	Change		2021		2022	Change
	Revenues:
		Net earned premiums
		Gross premiums	$	5,563	$	5,711	$	5,818	$	5,762	$	5,540	$	1,371	$	1,366		$	5,540	$	5,467
		Assumed (ceded)		—		(3)		(11)		(4)		73		19		22			73		103
		Total net earned premiums		5,563		5,708		5,808		5,758		5,613		1,391		1,388	(.2)		5,613		5,570	(.8)
		Adjusted net investment income		721		727		720		705		754		197		192	(2.5)		754		755	.1
		Other income excl. realized foreign
		exchange gains (losses)		5		8		22		102		121		31		41			121		161
		Total adjusted revenues		6,289		6,443		6,550		6,565		6,489		1,619		1,621	.1		6,489		6,486	—
	Benefits and claims:
		Benefits and claims, net
		Incurred claims -direct		2,526		2,560		2,611		2,498		2,183		598		526			2,183		2,245
		Incurred claims -assumed (ceded)		(4)		(4)		(5)		(1)		89		33		19			89		104
		Increase in FPB -direct		363		331		268		271		463		42		111			463		326
		Increase in FPB -assumed (ceded)		—		(1)		(2)		(3)		(11)		(2)		(2)			(11)		4
		Total benefits and claims, net, excluding   reserve remeasurement		N/A		N/A		N/A		N/A		2,724		672		655			2,724		2,679
		Reserve remeasurement gain (loss)		N/A		N/A		N/A		N/A		(85)		(11)		(41)			(85)		(124)
		Total benefits and claims, net		2,885		2,887		2,871		2,765		2,639		660		614	(7.0)		2,639		2,555	(3.2)
	Adjusted expenses:
		Amortization of deferred policy
		acquisition costs		502		534		573		570		442		110		115	4.5		442		455	2.9
		Insurance commissions		580		585		590		576		550		138		142	2.9		550		553	.5
		Insurance and other expenses		1,077		1,152		1,244		1,386		1,502		428		411	(4.0)		1,502		1,564	4.1
		Total adjusted expenses		2,159		2,271		2,407		2,532		2,494		676		667			2,494		2,573
		Total benefits and adjusted expenses		5,044		5,158		5,279		5,297		5,132		1,337		1,282	(4.1)		5,132		5,127	(.1)
		Pretax adjusted earnings	$	1,245	$	1,285	$	1,272	$	1,268	$	1,356	$	282	$	339	20.2	$	1,356	$	1,359	.2

16

Aflac U.S.
	Balance Sheets
	(In Millions)
			December 31,
			2017		2018		2019		2020		2021		2022
	Assets:
	Investments and cash		$	15,488	$	14,518	$	16,141	$	17,949	$	18,324	$	15,987
	Receivables, net of allowance for credit losses (1)			498		561		650		667		574		584
	Accrued investment income			184		178		174		172		169		184
	Deferred policy acquisition costs			3,355		3,491		3,544		3,450		3,366		3,463
	Other assets (1)			368		352		436		626		758		784
		Total assets	$	19,893	$	19,100	$	20,945	$	22,864	$	23,191	$	21,002
	Liabilities and Shareholders' Equity:
	Future policy benefits		$	8,806	$	9,137	$	9,404	$	9,674	$	14,212	$	10,870
	Policy and contract claims			1,700		1,727		1,779		2,010		151		200
	Other policy liabilities			119		116		111		126		119		117
	Deferred income taxes			982		(397)		51		235		(328)		(243)
	Other liabilities			1,625		1,577		1,803		2,016		2,010		2,080
	Shareholders' equity			6,661		6,939		7,796		8,803		7,027		7,978
		Total liabilities & shareholders' equity	$	19,893	$	19,100	$	20,945	$	22,864	$	23,191	$	21,002

(1) Certain reclassifications have been made to prior-year amounts to conform to current-year reporting classifications. These reclassifications had no impact on

net earnings or total shareholders' equity.

17

Aflac U.S.
Quarterly Statements of Pretax Adjusted Earnings and Percentage Changes
(Restated to conform to current classifications)
(Dollars In Millions)
		Net				Total		Benefits				Total		Pretax
		Earned	%	Adjusted	%	Adjusted	%	&	%		%	Adjusted	%	Adjusted	%
	Period	Premiums	Change	NII	Change	Revenues	Change	Claims, Net	Change	Amort.	Change	Expenses	Change	Earn.	Change
	2017	5,563	2.0	721	2.6	6,289	2.0	2,885	.6	502	1.0	2,159	3.3	1,245	3.1
	2018	5,708	2.6	727	.8	6,443	2.4	2,887	.1	534	6.4	2,271	5.2	1,285	3.2
	2019	5,808	1.8	720	(1.0)	6,550	1.7	2,871	(.6)	573	7.3	2,407	6.0	1,272	(1.0)
	2020	5,758	(.9)	705	(2.1)	6,565	.2	2,765	(3.7)	570	(.5)	2,532	5.2	1,268	(.3)
	2021	5,614	(2.5)	754	7.0	6,489	(1.2)	2,639	(4.6)	442	(22.5)	2,494	(1.5)	1,356	6.9
	2022	5,570	(.8)	755	.1	6,486	—	2,555	(3.2)	455	2.9	2,573	3.2	1,359	.2
2020	1	1,483	1.5	177	—	1,687	2.9	713	(1.1)	160	.6	648	8.7	326	.9
	2	1,458	(.1)	172	(4.4)	1,656	.9	646	(11.7)	134	2.3	584	2.3	426	26.0
	3	1,407	(2.6)	175	(4.4)	1,606	(1.5)	679	(4.4)	141	1.4	597	2.1	329	(1.8)
	4	1,410	(2.3)	182	1.1	1,617	(1.3)	727	2.5	135	(6.3)	703	7.5	187	(32.0)
2021	1	1,422	(4.1)	176	(.6)	1,628	(3.5)	696	(2.4)	111	(30.6)	600	(7.4)	331	1.5
	2	1,408	(3.4)	189	9.9	1,627	(1.8)	690	6.8	111	(17.2)	599	2.6	338	(20.7)
	3	1,393	(1.0)	191	9.1	1,616	.6	592	(12.8)	110	(22.0)	618	3.5	405	23.1
	4	1,391	(1.3)	197	8.2	1,619	.1	660	(9.2)	110	(18.5)	676	(3.8)	282	50.8
2022	1	1,413	(.6)	184	4.5	1,639	.7	666	(4.3)	114	2.7	640	6.7	333	.6
	2	1,394	(1.0)	193	2.1	1,628	.1	658	(4.6)	113	1.8	627	4.7	343	1.5
	3	1,375	(1.3)	185	(3.1)	1,599	(1.1)	616	4.1	114	3.6	638	3.2	345	(14.8)
	4	1,388	(0.2)	192	(2.5)	1,621	0.1	614	(7.0)	115	4.5	667	(1.3)	339	20.2

18

Aflac U.S.

Operating Ratios
(Before Management Fee)
		12-Mo. Rolling			Total Adjusted	Combined	Pretax
		Premium	Tot. Ben./	Amort./	Expenses/	Ratio/	Profit
	Period	Persistency (1)	Premium	Premium	Total Adj. Rev.	Total Adj. Rev.	Margin
	2017	78.4	51.9	9.0	34.3	80.2	19.8
	2018	78.7	50.6	9.4	35.2	80.1	19.9
	2019	77.7	49.4	9.9	36.7	80.6	19.4
	2020	79.3	48.0	9.9	38.6	80.7	19.3
	2021	79.6	47.0	7.9	38.4	79.1	20.9
	2022	77.0	45.9	8.2	39.7	79.0	21.0
2020	1	77.6	48.1	10.8	38.4	80.7	19.3
	2	78.3	44.3	9.2	35.3	74.3	25.7
	3	78.8	48.3	10.0	37.2	79.5	20.5
	4	79.3	51.6	9.6	43.5	88.4	11.6
2021	1	80.0	48.9	7.8	36.9	79.6	20.3
	2	80.1	49.0	7.9	36.8	79.2	20.8
	3	79.9	42.5	7.9	38.2	74.9	25.1
	4	79.6	47.4	7.9	41.8	82.6	17.4
2022	1	78.5	47.1	8.1	39.0	79.7	20.3
	2	77.9	47.2	8.1	38.5	78.9	21.1
	3	77.6	44.8	8.3	39.9	78.4	21.6
	4	77.0	44.2	8.3	41.1	79.1	20.9
(1) Excludes Network Dental & Vision, Consumer Markets, and Group Premier Life, Absence Management, and Disability Solutions products

19

Aflac U.S.

Aflac U.S. Sales Results
(Dollars In Millions)
		Annl.			New Annl.
		Prem.		%	Prem.		%
	Period	In Force		Change	Sales		Change
	2017		6,052	2.6		1,552	4.7
	2018		6,231	3.0		1,601	3.2
	2019		6,301	1.1		1,580	(1.3)
	2020		6,099	(3.2)		1,093	(30.8)
	2021		6,003	(1.6)		1,278	16.9
	2022		5,967	(.6)		1,483	16.1
2020	1		6,224	.7		323	(5.2)
	2		6,079	(1.7)		161	(55.6)
	3		5,969	(2.9)		221	(35.7)
	4		6,099	(3.2)		388	(27.2)
2021	1		6,027	(3.2)		251	(22.1)
	2		5,988	(1.5)		264	64.1
	3		5,929	(.7)		299	35.0
	4		6,003	(1.6)		464	19.6
2022	1		5,942	(1.4)		299	19.0
	2		5,926	(1.0)		305	15.6
	3		5,889	(.7)		334	11.8
	4		5,967	(.6)		545	17.4

20

Aflac U.S.

Aflac U.S. Product Mix
(New Annualized Premium Sales, Dollars in Millions)
				% of		% of		% of	Critical	% of	Hospital	% of	Dental/	% of
		Period	Disability	Total	Life	Total	Accident	Total	Care(1)	Total	Indemnity	Total	Vision	Total	Total
		2017	356	22.9	78	5.0	456	29.4	354	22.8	229	14.8	79	5.1	1,552
		2018	363	22.7	88	5.5	468	29.2	354	22.1	253	15.8	75	4.7	1,601
		2019	355	22.5	97	6.1	450	28.5	346	21.9	263	16.6	69	4.4	1,580
		2020	243	22.3	80	7.3	285	26.1	242	22.2	197	18.0	45	4.1	1,093
		2021	296	23.1	114	9.0	321	25.1	273	21.3	209	16.4	65	5.1	1,278
		2022	378	25.5	156	10.5	338	22.8	299	20.1	226	15.3	85	5.8	1,483
	2020	1	73	22.6	25	7.7	88	27.3	68	21.1	55	16.9	14	4.4	323
		2	38	23.9	14	8.6	41	25.7	33	20.6	28	17.1	7	4.1	161
		3	54	24.2	16	7.1	58	26.4	45	20.5	37	16.8	11	5.0	221
		4	79	20.4	26	6.6	98	25.2	95	24.5	77	20.0	13	3.3	388
	2021	1	58	23.1	17	6.7	66	26.3	57	22.6	42	16.7	11	4.6	251
		2	60	22.7	19	7.3	72	27.2	56	21.0	43	16.4	14	5.4	264
		3	79	26.2	27	9.2	76	25.5	57	19.1	45	15.1	15	4.9	299
		4	100	21.4	51	11.0	107	23.1	104	22.3	79	17.0	24	5.2	464
	2022	1	70	23.3	24	7.9	75	25.3	63	21.2	50	16.7	17	5.6	299
		2	77	25.2	26	8.3	75	24.6	63	20.6	45	14.9	19	6.4	305
		3	97	28.9	33	10.0	76	22.6	60	18.1	47	14.1	21	6.3	334
		4	135	24.9	73	13.4	112	20.5	112	20.6	84	15.4	28	5.2	545

Aflac U.S. Sales Force Data
					Average	Productivity
					Weekly	(Production/
		Recruited Agents			Producer	Avg. Weekly
	Period	Career	Broker	Total	Equivalents	Producers)
	2017	16,817	3,073	19,890	8,808	176,183
	2018	15,774	3,380	19,154	8,531	187,720
	2019	15,227	3,603	18,830	8,184	193,120
	2020	11,826	1,861	13,687	5,918	184,706
	2021	10,641	5,445	16,086	5,993	213,235
	2022	9,550	1,500	11,050	6,186	239,786
2020	1	3,436	494	3,930	7,411	43,517
	2	2,190	381	2,571	4,252	37,814
	3	3,136	486	3,622	5,485	40,367
	4	3,064	500	3,564	6,523	59,533
2021	1	2,890	1,063	3,953	5,643	44,530
	2	2,754	1,355	4,109	5,925	44,540
	3	2,502	1,615	4,117	5,926	50,448
	4	2,495	1,412	3,907	6,477	71,723
2022	1	1,987	455	2,442	6,061	49,322
	2	2,937	391	3,328	6,067	50,264
	3	2,358	339	2,697	6,010	55,599
	4	2,268	315	2,583	6,607	82,538

(1) Includes cancer, critical illness, and hospital intensive care products

21

Aflac Japan

Statements of Pretax Adjusted Earnings
(Before Management Fee)
(In Millions)
		Years Ended December 31,										3 Months Ended December 31,					12 Months Ended December 31,
																%					%
		2017		2018		2019		2020		2021		2021		2022		Change	2021		2022		Change
Revenues:
	Net earned premiums
	Gross premiums	¥	1,493,299	¥	1,468,894	¥	1,450,586	¥	1,409,134	¥	1,290,527	¥	319,367	¥	309,305		¥	1,290,527	¥	1,246,657
	Assumed (ceded)		(62,873)		(60,198)		(57,974)		(55,926)		(50,864)		(12,555)		(11,990)			(50,864)		(48,578)
	Total net earned premiums		1,430,426		1,408,697		1,392,612		1,353,208		1,239,663		306,812		297,315	(3.1)		1,239,663		1,198,079	(3.4)
	Net investment income (1)
	Yen denominated		145,114		141,575		142,473		138,397		138,513		34,321		34,272	(.1)		138,513		149,449	7.9
	US$ denominated		131,168		149,801		157,717		167,541		202,905		55,667		55,386	(.5)		202,905		215,171	6.0
	Net investment income		276,282		291,377		300,191		305,938		341,419		89,988		89,658	(.4)		341,419		364,621	6.8
	Amortized hedge costs on foreign investments (2)		(24,528)		(25,858)		(28,938)		(22,816)		(8,391)		(2,297)		(3,478)	51.4		(8,391)		(13,155)	56.8
	Adjusted net investment income		251,754		265,519		271,253		283,122		333,028		87,690		86,180	(1.7)		333,028		351,466	5.5
	Other income excl. realized foreign
	currency gains (losses)		4,640		4,636		4,869		4,497		4,512		1,071		1,023			4,512		4,442
	Total adjusted revenues		1,686,820		1,678,852		1,668,734		1,640,827		1,577,203		395,573		384,517	(2.8)		1,577,203		1,553,988	(1.5)
Benefits and claims:
	Benefits and claims, net
	Incurred claims -direct		710,251		724,556		727,491		734,471		743,247		182,324		184,223			743,247		788,572
	Incurred claims -assumed (ceded)		(55,691)		(51,892)		(45,657)		(37,806)		(31,798)		(8,112)		(7,091)			(31,798)		(36,141)
	Increase in FPB -direct		366,376		313,343		292,444		260,200		149,084		37,389		28,524			149,084		73,592
	Increase in FPB -assumed (ceded)		(1,557)		(2,000)		(6,497)		(11,377)		(11,425)		(2,559)		(3,343)			(11,425)		(5,618)
	Total benefits and claims, net, excluding reserve       remeasurement		N/A		N/A		N/A		N/A		849,108		209,041		202,312			849,108		820,405
	Reserve remeasurement gain (loss)		N/A		N/A		N/A		N/A		(6,879)		(898)		(3,062)			(6,879)		(13,337)
	Total benefits and claims, net		1,019,378		984,007		967,782		945,487		842,229		208,143		199,250	(2.8)		842,229		807,068	(2.6)
Adjusted expenses:
	Amortization of deferred policy
	acquisition costs		70,670		78,459		77,286		68,818		43,131		11,134		11,201	.6		43,131		44,123	2.3
	Insurance commissions		82,495		81,045		79,661		79,036		77,449		18,796		18,155	(3.4)		77,449		73,482	(5.1)
	Insurance and other expenses		170,636		181,139		189,203		199,606		202,586		55,527		53,126	(4.3)		202,586		198,493	(2.0)
	Total adjusted expenses		323,801		340,643		346,150		347,460		323,166		85,457		82,482			323,166		316,097
	Total benefits and adjusted expenses		1,343,180		1,324,651		1,313,932		1,292,947		1,165,395		293,601		281,732	(4.0)		1,165,395		1,123,165	(3.6)
	Pretax adjusted earnings	¥	343,640	¥	354,201	¥	354,802	¥	347,881	¥	411,808	¥	101,973	¥	102,785	.8	¥	411,808	¥	430,823	4.6
	(1) Includes the net interest cash flows from derivatives associated with certain investment strategies
	(2) See non-U.S. GAAP financial measures for the definition of amortized hedge costs/income

22

Aflac Japan

Statements of Pretax Adjusted Earnings
(Before Management Fee)
(In Millions)
		Years Ended December 31,										3 Months Ended December 31,						12 Months Ended December 31,
																	%					%
		2017		2018		2019		2020		2021		2021			2022		Change	2021		2022		Change
Revenues:
	Net earned premiums
	Gross premiums	$	13,312	$	13,307	$	13,304	$	13,193	$	11,765	$	2,809		$	2,187		$	11,765	$	9,558
	Assumed (ceded)		(561)		(546)		(532)		(524)		(463)		(110)			(85)			(463)		(372)
	Total net earned premiums		12,752		12,762		12,772		12,670		11,301		2,698			2,102	(22.1)		11,301		9,186	(18.7)
	Net investment income (1)
	Yen denominated		1,294		1,283		1,307		1,296		1,262		302			242	(19.9)		1,262		1,140	(9.7)
	US$ denominated		1,169		1,356		1,446		1,569		1,845		490			390	(20.4)		1,845		1,641	(11.1)
	Net investment income		2,463		2,639		2,753		2,865		3,107		792			632	(20.2)		3,107		2,782	(10.5)
	Amortized hedge costs on foreign investments (2)		(228)		(236)		(257)		(206)		(76)		(21)			(28)	33.3		(76)		(112)	47.4
	Adjusted net investment income		2,235		2,403		2,496		2,659		3,031		771			604	(21.7)		3,031		2,669	(11.9)
	Other income excl. realized foreign
	currency gains (losses)		41		41		45		42		41		10			7			41		35
	Total adjusted revenues		15,028		15,206		15,313		15,371		14,373		3,478			2,713	(22.0)		14,373		11,889	(17.3)
Benefits and claims
	Benefits and claims, net
	Incurred claims -direct		6,332		6,566		6,671		6,875		6,776		1,603			1,303			6,776		6,038
	Incurred claims -assumed (ceded)		(497)		(471)		(419)		(354)		(290)		(71)			(50)			(290)		(275)
	Increase in FPB -direct		3,265		2,836		2,684		2,437		1,356		327			201			1,356		562
	Increase in FPB -assumed (ceded)		(14)		(18)		(60)		(107)		(104)		(22)			(23)			(104)		(43)
	Total benefits and claims, net, excluding reserve       remeasurement		N/A		N/A		N/A		N/A		7,738		1,837			1,431			7,738		6,282
	Reserve remeasurement gain (loss)		N/A		N/A		N/A		N/A		(62)		(6)			(22)			(62)		(91)
	Total benefits and claims, net		9,087		8,913		8,877		8,851		7,675		1,830			1,408	(21.8)		7,675		6,191	(18.1)
Adjusted expenses:
	Amortization of deferred policy
	acquisition costs		630		710		709		644		393		98	55		79	(19.4)		393		338	(14.0)
	Insurance commissions		736		735		731		740		706		165			128	(22.4)		706		563	(20.3)
	Insurance and other expenses		1,521		1,640		1,734		1,873		1,843		488			377	(22.7)		1,843		1,517	(17.7)
	Total adjusted expenses		2,887		3,085		3,174		3,257		2,942		751			584			2,942		2,417
	Total benefits and adjusted expenses		11,974		11,998		12,051		12,108		10,618		2,582			1,993	(22.8)		10,618		8,609	(18.9)
	Pretax adjusted earnings	$	3,054	$	3,208	$	3,261	$	3,263	$	3,755	$	897		$	720	(19.7)	$	3,755	$	3,281	(12.6)
	(1) Includes the net interest cash flows from derivatives associated with certain investment strategies
	(2) See non-U.S. GAAP financial measures for definition of amortized hedge costs/income

23

Aflac Japan

Balance Sheets
(In Millions)
	December 31,
	2017		2018		2019		2020		2021		2022
Assets:
Investments and cash	¥	11,854,224	¥	12,031,549	¥	12,847,994	¥	13,080,154	¥	13,645,902	¥	12,777,746
Receivables, net of allowance for credit losses		37,692		37,083		28,219		20,782		22,439		23,138
Accrued investment income		64,439		66,350		65,485		62,722		67,493		76,489
Deferred policy acquisition costs		695,025		708,638		721,341		723,579		745,510		766,506
Other assets		276,050		292,335		308,411		320,351		386,832		387,065
Total assets	¥	12,927,431	¥	13,135,956	¥	13,971,450	¥	14,207,588	¥	14,868,176	¥	14,030,944
Liabilities and Shareholders' Equity:
Future policy benefits	¥	8,323,560	¥	8,637,152	¥	8,924,868	¥	9,175,501	¥	11,755,704	¥	10,315,140
Policy and contract claims		304,248		317,043		315,477		328,778		—		28
Unearned premiums		659,977		552,419		453,133		361,010		284,045		227,732
Other policyholders' funds		784,117		793,148		801,588		808,429		877,690		880,989
Income taxes (prim. deferred)		431,949		510,528		618,901		478,969		36,166		114,688
Other liabilities		150,143		194,949		357,135		253,219		502,633		575,554
Shareholders' equity		2,273,438		2,130,718		2,500,349		2,801,682		1,411,938		1,916,812
Total liabilities & shareholders' equity	¥	12,927,431	¥	13,135,956	¥	13,971,450	¥	14,207,588	¥	14,868,176	¥	14,030,944

24

Aflac Japan

Balance Sheets
(In Millions)
	December 31,
	2017		2018		2019		2020		2021		2022
Assets:
Investments and cash	$	104,905	$	108,392	$	117,269	$	126,378	$	118,639	$	96,290
Receivables, net of allowance for credit losses		334		334		258		201		195		174
Accrued investment income		570		598		598		606		587		576
Deferred policy acquisition costs		6,150		6,384		6,584		6,991		6,482		5,776
Other assets		2,443		2,634		2,815		3,095		3,363		2,917
Total assets	$	114,402	$	118,342	$	127,523	$	137,271	$	129,266	$	105,734
Liabilities and Shareholders' Equity:
Future policy benefits	$	73,661	$	77,812	$	81,461	$	88,652	$	102,206	$	77,733
Policy and contract claims		2,692		2,856		2,879		3,177		—		—
Unearned premiums		5,840		4,977		4,136		3,488		2,470		1,716
Other policyholders' funds		6,939		7,145		7,316		7,811		7,631		6,639
Income taxes (prim. deferred)		3,823		4,601		5,650		4,630		314		781
Other liabilities		1,328		1,756		3,260		2,447		4,369		4,337
Shareholders' equity		20,119		19,194		22,820		27,068		12,276		14,528
Total liabilities & shareholders' equity	$	114,402	$	118,342	$	127,523	$	137,271	$	129,266	$	105,734

25

Aflac Japan

Quarterly Statements of Pretax Adjusted Earnings and Percentage Changes
(Yen In Millions)
		Net						Total			Benefits						Total			Pretax
		Earned		%	Adjusted		%	Adjusted		%	&		%			%	Adjusted		%	Adjusted		%
	Period	Premiums		Change	NII		Change	Revenues		Change	Claims, Net		Change	Amort.		Change	Expense		Change	Earn.		Change
	2017		1,430,426	(2.7)		251,754	(2.0)		1,686,820	(2.5)		1,019,378	(4.5)		70,670	1.2		323,801	.5		343,640	.6
	2018		1,408,697	(1.5)		265,519	5.5		1,678,852	(.5)		984,007	(3.5)		78,460	11.0		340,642	5.2		354,201	3.1
	2019		1,392,612	(1.1)		271,253	2.2		1,668,734	(.6)		967,782	(1.6)		77,286	(1.5)		346,150	1.6		354,802	.2
	2020		1,353,208	(2.8)		283,122	4.4		1,640,827	(1.7)		945,487	(2.3)		68,818	(11.0)		347,459	.4		347,881	(2.0)
	2021		1,239,663	(8.4)		333,028	17.6		1,577,203	(3.9)		842,229	(10.9)		43,131	(37.3)		323,166	(7.0)		411,808	18.4
	2022		1,198,079	(3.4)		351,466	5.5		1,553,988	(1.5)		807,068	(4.2)		44,123	2.3		316,097	(2.2)		430,823	4.6
2020	1		343,054	(2.1)		69,812	4.0		414,045	(1.1)		238,148	(1.7)		18,842	(5.9)		82,939	(2.0)		92,958	1.2
	2		339,891	(2.5)		68,036	2.0		409,126	(1.8)		237,328	(1.2)		16,697	(14.3)		81,648	(4.1)		90,150	(1.2)
	3		336,488	(3.3)		70,219	(.2)		407,874	(2.8)		240,025	(1.4)		16,001	(16.5)		88,661	2.5		79,188	(11.6)
	4		333,775	(3.5)		75,054	11.9		409,782	(1.0)		229,986	(4.9)		17,277	(7.2)		94,211	4.9		85,585	4.2
2021	1		313,769	(8.5)		74,621	6.9		389,679	(5.9)		215,445	(9.5)		10,534	(44.1)		77,715	(6.3)		96,519	3.8
	2		311,733	(8.3)		86,681	27.4		399,488	(2.4)		212,617	(10.4)		10,700	(35.9)		79,234	(3.0)		107,637	19.4
	3		307,350	(8.7)		84,035	19.7		392,463	(3.8)		206,023	(14.2)		10,762	(32.7)		80,760	(8.9)		105,680	33.5
	4		306,812	(8.1)		87,690	16.8		395,573	(3.5)		208,143	(9.5)		11,134	(35.6)		85,457	(9.3)		101,973	19.1
2022	1		304,884	(2.8)		79,042	5.9		385,000	(1.2)		206,890	(4.0)		10,886	3.3		77,095	(.8)		101,015	4.7
	2		302,213	(3.1)		94,004	8.4		397,358	(.5)		204,807	(3.7)		10,964	2.5		79,022	(.3)		113,529	5.5
	3		293,667	(4.5)		92,241	9.8		387,113	(1.4)		196,121	(4.8)		11,073	2.9		77,498	(4.0)		113,494	7.4
	4		297,315	(3.1)		86,180	(1.7)		384,517	(2.8)		199,250	(4.3)		11,201	.6		82,482	(3.5)		102,785	.8

26

Aflac Japan

Operating Ratios
(Before Management Fee)
		12-Mo. Rolling		Tot. Ben./		Tot. Adj.	Combined	Pretax
		Premium	Tot. Ben./	Premiums	Amort./	Expenses/	Ratio/	Profit
	Period	Persistency(1)	Premium	(3rd sector)	Premium	Total Adj. Rev.	Total Adj. Rev.	Margin
	2017	94.9	71.3	60.5	4.9	19.2	79.6	20.4
	2018	94.1	69.9	59.2	5.6	20.3	78.9	21.1
	2019	94.4	69.5	59.3	5.5	20.7	78.7	21.3
	2020	95.1	69.9	59.7	5.1	21.2	78.8	21.2
	2021	94.3	67.9	58.7	3.5	20.5	73.9	26.1
	2022	94.1	67.4	58.5	3.7	20.3	72.3	27.7
2020	1	94.5	69.4	59.0	5.5	20.0	77.5	22.5
	2	94.8	69.8	59.6	4.9	20.0	78.0	22.0
	3	95.0	71.3	61.7	4.8	21.7	80.6	19.4
	4	95.1	68.9	58.6	5.2	23.0	79.1	20.9
2021	1	95.0	68.7	59.6	3.4	19.9	75.2	24.8
	2	94.7	68.2	59.0	3.4	19.8	73.1	26.9
	3	94.5	67.0	57.8	3.5	20.6	73.1	26.9
	4	94.3	67.8	58.4	3.6	21.6	74.2	25.8
2022	1	94.3	67.9	58.5	3.6	20.0	73.8	26.2
	2	94.3	67.8	58.5	3.6	19.9	71.4	28.6
	3	94.3	66.8	59.4	3.8	20.0	70.7	29.3
	4	94.1	67.0	57.7	3.8	21.5	73.3	26.7

(1) Premium persistency presented on a 12-month rolling basis for all periods, rather than year to date

27

Aflac Japan

Aflac Japan Sales Results
(Yen In Millions, unless otherwise noted)
		Annl.			Third Sector
		Prem.			New Annl.			Total
		In Force		%	Prem.		%	New Annual.		%
	Period	(Billions)		Change	Sales		Change	Premium Sales		Change
	2017		1,552.2	(3.4)		87,417	4.1		94,851	(16.6)
	2018		1,527.1	(1.6)		88,813	1.6		95,894	1.1
	2019		1,489.3	(2.5)		72,836	(18.0)		79,697	(16.9)
	2020		1,426.5	(4.2)		45,110	(38.1)		50,852	(36.2)
	2021		1,360.6	(4.7)		48,977	8.6		54,764	7.7
	2022		1,301.0	(4.4)		47,998	(2.0)		54,765	—
2020	1		1,474.3	(2.8)		12,486	(26.7)		14,021	(25.4)
	2		1,457.7	(3.4)		8,656	(60.9)		9,827	(58.8)
	3		1,441.9	(.5)		11,167	(33.7)		12,601	(32.0)
	4		1,426.5	(4.2)		12,801	(23.8)		14,404	(22.2)
2021	1		1,410.0	(4.4)		12,492	—		13,998	(.2)
	2		1,391.7	(4.5)		12,125	40.1		13,602	38.4
	3		1,375.0	(4.6)		11,275	1.0		12,605	—
	4		1,360.6	(4.7)		13,084	2.2		14,559	1.1
2022	1		1,345.6	(4.6)		10,679	(19.0)		11,925	(14.8)
	2		1,332.0	(4.3)		11,372	(6.2)		12,731	(6.4)
	3		1,315.7	(4.3)		12,639	12.1		13,884	10.2
	4		1,301.0	(4.4)		13,308	1.7		16,224	11.4

28

Aflac Japan

Aflac Japan Product Mix
(New Annualized Premium Sales, Yen In Billions)
			% of		% of	Income	% of	Child	% of		% of	Ordinary	% of		% of
	Period	Cancer	Total	Medical	Total	Support	Total	Endowment	Total	WAYS	Total	Life Other	Total	Other	Total	Total
	2017	53.0	55.8	32.4	34.1	2.2	2.3	.5	.5	.6	.6	5.6	6.0	.6	.7	94.9
	2018	63.1	65.8	23.9	25.0	1.7	1.8	.3	.3	.5	.5	5.9	6.1	.5	.5	95.9
	2019	47.2	59.2	24.6	31.0	1.0	1.2	.2	.2	.4	.5	5.9	7.4	.4	.5	79.7
	2020	28.8	56.6	15.9	31.2	.5	1.0	.2	.4	.4	.7	4.8	9.5	.3	.6	50.9
	2021	27.0	49.2	20.4	37.2	.3	.5	.2	.3	.4	.8	4.9	9.0	1.6	3.0	54.8
	2022	30.9	56.5	14.6	26.6	.7	1.3	.2	.3	1.9	3.5	4.5	8.1	2.0	3.7	54.8
2020	1	7.8	55.5	4.5	32.4	.2	1.2	—	.3	.1	.6	1.3	9.3	.1	.7	14.0
	2	5.4	54.7	3.2	32.5	.1	.9	—	.4	.1	.8	1.0	10.0	—	.7	9.8
	3	7.0	55.7	4.0	32.0	.1	.9	.1	.4	.1	.8	1.2	9.6	.1	.6	12.6
	4	8.6	59.7	4.1	28.4	.1	.8	.1	.3	.1	.8	1.3	9.3	.1	.7	14.4
2021	1	6.4	45.4	6.1	43.3	.1	.6	—	.3	.1	.7	1.2	8.9	.1	.8	14.0
	2	6.7	48.9	5.4	39.7	.1	.6	—	.4	.1	.8	1.2	8.9	.1	.7	13.6
	3	6.3	49.9	4.6	36.3	.1	.5	—	.3	.1	.7	1.1	9.0	.4	3.3	12.6
	4	7.7	52.7	4.4	29.9	.1	.4	—	.3	.1	.8	1.2	8.6	1.1	7.3	14.6
2022	1	6.4	53.0	3.8	31.4	.1	1.1	.1	.3	.1	.7	1.1	9.0	.5	4.5	11.9
	2	6.8	53.4	3.8	29.9	.3	2.2	—	.2	.1	.8	1.2	9.2	.6	4.3	12.7
	3	8.4	60.1	3.7	26.4	.2	1.2	—	.2	.1	.6	1.0	7.7	.5	3.8	13.9
	4	9.5	58.2	3.4	20.8	.1	.8	.1	.4	1.6	10.1	1.1	7.2	.4	2.5	16.2

29

Aflac Japan

Aflac Japan Sales Force Data
			Number of Agencies by Type				Sales Contribution by Agency Type
		Period	Individual/ Independent Corporate	Affiliated Corporate	Bank	Total	Individual/ Independent Corporate	Affiliated Corporate	Bank	Licensed Sales Associates(1)	Recruited Agencies
		2017	9,492	1,455	374	11,321	42.8	52.0	5.2	109,197	174
		2018	8,453	1,392	371	10,216	40.1	55.3	4.6	109,482	85
		2019	7,683	1,343	367	9,393	45.7	50.0	4.3	109,265	77
		2020	7,231	1,312	361	8,904	52.3	42.6	5.1	111,886	48
		2021	6,779	1,283	360	8,422	51.1	43.7	5.2	111,854	62
		2022	6,159	1,239	359	7,757	49.5	46.5	4.0	110,259	38
	2020	1	7,537	1,332	364	9,233	52.8	42.7	4.5	110,129	17
		2	7,426	1,329	364	9,119	53.8	42.8	3.4	109,850	5
		3	7,312	1,317	364	8,993	51.7	41.4	6.9	111,016	19
		4	7,231	1,312	361	8,904	51.3	43.4	5.3	111,886	7
	2021	1	7,142	1,308	360	8,810	54.3	40.6	5.1	112,252	13
		2	7,055	1,305	359	8,719	51.1	44.0	4.9	113,259	22
		3	6,898	1,299	360	8,557	49.9	43.8	6.3	112,100	13
		4	6,779	1,283	360	8,422	49.2	46.3	4.5	111,854	14
	2022	1	6,447	1,266	360	8,073	48.9	46.5	4.6	109,873	6
		2	6,335	1,255	359	7,949	48.4	48.1	3.5	110,096	12
		3	6,260	1,246	359	7,865	49.3	46.2	4.5	110,400	12
		4	6,159	1,239	359	7,757	51.2	45.4	3.4	110,259	8

(1) Excludes Dai-ichi Life, banks, Japan Post Group and Daido Life

30

Aflac Japan

Yen/Dollar Exchange Rates
				Yearly
		Closing	Qtr	Cum	%
	Period	Rate(1)	Avg	Avg	Change
	2017	113.00	N/A	112.16	(3.1)
	2018	111.00	N/A	110.39	1.6
	2019	109.56	N/A	109.07	1.2
	2020	103.50	N/A	106.86	2.1
	2021	115.02	N/A	109.79	(2.7)
	2022	132.70	N/A	130.17	(15.7)
2020	1	108.83	108.84	108.84	1.3
	2	107.74	107.65	108.25	1.7
	3	105.80	106.23	107.63	1.4
	4	103.50	104.57	106.86	2.1
2021	1	110.71	105.88	105.88	2.8
	2	110.58	109.48	107.79	.4
	3	111.92	110.11	108.58	(.9)
	4	115.02	113.70	109.79	(2.7)
2022	1	122.39	116.18	116.18	(8.9)
	2	136.68	129.39	122.79	(12.2)
	3	144.81	137.08	126.65	(14.3)
	4	132.70	141.87	130.17	(15.7)
	(1) Closing rate is based on the latest available and published MUFG Bank Ltd. TTM mid-day exchange rate.

31

Corporate and Other

Statements of Pretax Adjusted Earnings
(Before Management Fee)
(In Millions)
		Years Ended December 31,															3 Months Ended December 31,							12 Months Ended December 31,
																							%							%
		2017			2018			2019			2020			2021			2021			2022			Change	2021			2022			Change
Revenues:
	Total net earned premiums		$	216		$	208		$	200		$	194		$	180		$	42		$	33	(21.4)		$	180		$	145	(19.4)
	Net investment income (1)		35			77			88			80			(73)			(88)			19		121.6		(73)			30		141.1
	Amortized hedge income (2)		—			36			89			97			57			11			25		127.3		57			68		19.3
	Adjusted net investment income		35			113			177			177			(16)			(77)			44		157.1		(16)			98		712.5
	Other income		21			18			15			13			11			—			2		—		11			24		118.2
	Total adjusted revenues		272			339			393			384			175			(35)			79		325.7		175			267		52.6
Benefits and expenses:
	Total net benefits and claims		209			199			194			180			161			38			31		(18.4)		161			141		(12.4)
	Interest expense		122			120			133			164			165			39			39		—		165			162		(1.8)
	Other adjusted expenses		154			159			137			155			142			40			53		32.5		142			181		27.5
	Total benefits and adjusted expenses		486			478			464			499			469			118			123		4.2		469			485		3.4
	Pretax adjusted earnings		$	(214)		$	(139)		$	(72)		$	(115)		$	(293)		$	(152)		$	(45)	70.4		$	(293)		$	(218)	25.6
	(1) The change in value of federal historic rehabilitation and solar investments in partnerships of $11 and $104 for the three-month periods and $91 and $138 for the twelve-month periods ended December 31, 2022, and 2021, respectively is included as a reduction to net investment income. Tax credits on these investments of $20 and $80 for the three-month period and $83 and $115 for the twelve-month periods ended December 31, 2022, and 2021, respectively, have been recorded as an income tax benefit in the consolidated statement of earnings.
	(2) See non-U.S. GAAP financial measures for the definition of amortized hedge cost/income

32

Non-U.S. GAAP Financial Measures

This document includes references to the Company’s financial performance measures which are not calculated in accordance with United States generally accepted accounting principles (U.S. GAAP) (non-U.S. GAAP). The financial measures exclude items that the Company believes may obscure the underlying fundamentals and trends in insurance operations because they tend to be driven by general economic conditions and events or related to infrequent activities not directly associated with insurance operations.

Due to the size of Aflac Japan, where the functional currency is the Japanese yen, fluctuations in the yen/dollar exchange rate can have a significant effect on reported results. In periods when the yen weakens, translating yen into dollars results in fewer dollars being reported. When the yen strengthens, translating yen into dollars results in more dollars being reported. Consequently, yen weakening has the effect of suppressing current period results in relation to the comparable prior period, while yen strengthening has the effect of magnifying current period results in relation to the comparable prior period. A significant portion of the Company’s business is conducted in yen and never converted into dollars but translated into dollars for U.S. GAAP reporting purposes, which results in foreign currency impact to earnings, cash flows and book value on a U.S. GAAP basis. Management evaluates the Company's financial performance both including and excluding the impact of foreign currency translation to monitor, respectively, cumulative currency impacts and the currency-neutral operating performance over time. The average yen/dollar exchange rate is based on the published MUFG Bank, Ltd. telegraphic transfer middle rate (TTM).

The Company defines the non-U.S. GAAP financial measures included in this document as follows:

• Adjusted book value is the U.S. GAAP book value (representing total shareholders’ equity), less AOCI as recorded on the U.S. GAAP balance sheet. Adjusted book value per common share is adjusted book value at the period end divided by the ending outstanding common shares for the period presented. The Company considers adjusted book value and adjusted book value per common share important as they exclude AOCI, which fluctuates due to market movements that are outside management’s control. The most comparable U.S. GAAP financial measures for adjusted book value and adjusted book value per common share are total book value and total book value per common share, respectively.

• Adjusted book value including unrealized foreign currency translation gains and losses is adjusted book value plus unrealized foreign currency translation gains and losses. Adjusted book value including unrealized foreign currency translation gains and losses per common share is adjusted book value plus unrealized foreign currency translation gains and losses at the period end divided by the ending outstanding common shares for the period presented. The Company considers adjusted book value including unrealized foreign currency translation gains and losses, and its related per share financial measure, important as they exclude certain components of AOCI, which fluctuate due to market movements that are outside management's control; however, it includes the impact of foreign currency as a result of the significance of Aflac’s Japan operation. The most comparable U.S. GAAP financial measures for adjusted book value including unrealized foreign currency translation gains and losses and adjusted book value including unrealized foreign currency translation gains and losses per common share are total book value and total book value per common share, respectively.

• Adjusted book value including unrealized foreign currency translation gains and losses and pension liability adjustment is adjusted book value plus unrealized foreign currency translation gains and losses and pension liability adjustment. The Company considers adjusted book value including unrealized foreign currency translation gains and losses and pension liability adjustment important as it excludes certain components of AOCI, which fluctuates due to market movements that are outside management's control; however, it includes the impact of foreign currency as a result of the significance of Aflac’s Japan operation. The most comparable U.S. GAAP financial measure for adjusted book value including unrealized foreign currency translation gains and losses and pension liability adjustment is total book value.

• Adjusted debt is the sum of notes payable, as recorded on the U.S. GAAP balance sheet, excluding 50% of subordinated debentures and perpetual bonds and all pre-funding of debt maturities. The Company considers adjusted debt important as it measures outstanding debt consistently with expectations of the Company’s rating agency stakeholders. The most comparable U.S. GAAP financial measure for adjusted debt is notes payable.

• Adjusted debt including 50% of subordinated debentures and perpetual bonds is the sum of notes payable, as recorded on the U.S. GAAP balance sheet, excluding pre-funding of debt maturities. The Company considers adjusted debt including 50% of subordinated debentures and perpetual bonds important as it measures outstanding debt consistently with expectations of the Company’s rating agency stakeholders. The most comparable U.S. GAAP financial measure for adjusted debt including 50% of subordinated debentures and perpetual bonds is notes payable.

33

• Adjusted earnings are adjusted revenues less benefits and adjusted expenses. Adjusted earnings per share (basic or diluted) are the adjusted earnings for the period divided by the weighted average outstanding shares (basic or diluted) for the period presented. The adjustments to both revenues and expenses account for certain items that cannot be predicted or that are outside management’s control. Adjusted revenues are U.S. GAAP total revenues excluding adjusted net investment gains and losses. Adjusted expenses are U.S. GAAP total acquisition and operating expenses including the impact of interest cash flows from derivatives associated with notes payable but excluding any nonrecurring or other items not associated with the normal course of the Company’s insurance operations and that do not reflect the Company's underlying business performance. Management uses adjusted earnings and adjusted earnings per diluted share to evaluate the financial performance of the Company’s insurance operations on a consolidated basis and believes that a presentation of these financial measures is vitally important to an understanding of the underlying profitability drivers and trends of the Company’s insurance business. The most comparable U.S. GAAP financial measures for adjusted earnings and adjusted earnings per share (basic or diluted) are net earnings and net earnings per share, respectively.

• Adjusted earnings excluding current period foreign currency impact are computed using the average foreign currency exchange rate for the comparable prior-year period, which eliminates fluctuations driven solely by foreign currency exchange rate changes. Adjusted earnings per diluted share excluding current period foreign currency impact is adjusted earnings excluding current period foreign currency impact divided by the weighted average outstanding diluted shares for the period presented. The Company considers adjusted earnings excluding current period foreign currency impact and adjusted earnings per diluted share excluding current period foreign currency impact important because a significant portion of the Company's business is conducted in Japan and foreign exchange rates are outside management’s control; therefore, the Company believes it is important to understand the impact of translating foreign currency (primarily Japanese yen) into U.S. dollars. The most comparable U.S. GAAP financial measures for adjusted earnings excluding current period foreign currency impact and adjusted earnings per diluted share excluding current period foreign currency impact are net earnings and net earnings per share, respectively.

• Amortized hedge costs/income represent costs/income incurred or recognized as a result of using foreign currency derivatives to hedge certain foreign exchange risks in the Company's Japan segment or in Corporate and other. These amortized hedge costs/ income are estimated at the inception of the derivatives based on the specific terms of each contract and are recognized on a straight-line basis over the term of the hedge. The Company believes that amortized hedge costs/income measure the periodic currency risk management costs/income related to hedging certain foreign currency exchange risks and are an important component of net investment income. There is no comparable U.S. GAAP financial measure for amortized hedge costs/ income.

• Adjusted net investment gains and losses are net investment gains and losses adjusted for i) amortized hedge cost/income related to foreign currency exposure management strategies and certain derivative activity, ii) net interest cash flows from foreign currency and interest rate derivatives associated with certain investment strategies, which are both reclassified to net investment income, and iii) the impact of interest cash flows from derivatives associated with notes payable, which is reclassified to interest expense as a component of total adjusted expenses. The Company considers adjusted net investment gains and losses important as it represents the remainder amount that is considered outside management’s control, while excluding the components that are within management’s control and are accordingly reclassified to net investment income and interest expense. The most comparable U.S. GAAP financial measure for adjusted net investment gains and losses is net investment gains and losses.

• Adjusted net investment income is net investment income adjusted for i) amortized hedge cost/income related to foreign currency exposure management strategies and certain derivative activity, and ii) net interest cash flows from foreign currency and interest rate derivatives associated with certain investment strategies, which are reclassified from net investment gains and losses to net investment income. The Company considers adjusted net investment income important because it provides a more comprehensive understanding of the costs and income associated with the Company’s investments and related hedging strategies. The most comparable U.S. GAAP financial measure for adjusted net investment income is net investment income.

• Adjusted return on equity is adjusted earnings divided by average shareholders’ equity, excluding accumulated other comprehensive income (AOCI). Management uses adjusted return on equity to evaluate the financial performance of the Company’s insurance operations on a consolidated basis and believes that a presentation of this financial measure is vitally important to an understanding of the underlying profitability drivers and trends of the Company’s insurance business. The Company considers adjusted return on equity important as it excludes components of AOCI, which fluctuate due to market movements that are outside management's control. The most comparable U.S. GAAP financial measure for adjusted return on equity is return on average equity (ROE) as determined using net earnings and average total shareholders’ equity.

34

XML

Document and Entity Information Document	Feb. 27, 2023
Entity Central Index Key	0000004977
Document Type	8-K
Document Period End Date	Feb. 27, 2023
Entity Registrant Name	Aflac Incorporated
Entity Incorporation, State or Country Code	GA
Entity File Number	001-07434
Entity Tax Identification Number	58-1167100
Entity Address, Address Line One	1932 Wynnton Road
Entity Address, City or Town	Columbus
Entity Address, State or Province	GA
Entity Address, Postal Zip Code	31999
City Area Code	706
Local Phone Number	323.3431
Written Communications	false
Soliciting Material	false
Pre-commencement Tender Offer	false
Pre-commencement Issuer Tender Offer	false
Entity Emerging Growth Company	false
Amendment Flag	false
NEW YORK STOCK EXCHANGE, INC.
Title of 12(b) Security	Common Stock, $.10 Par Value
Trading Symbol	AFL
Security Exchange Name	NYSE